Skip to main content
logo
Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.5850
-0.0170 (-2.82%)
Sep 4, 2026, 3:25 PM EDT - Market open

[Name] Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Capitalization
162190109177296
Market Cap Growth
-26.67%-76.68%-16.79%-38.51%-40.33%413.63%
Enterprise Value
6197377130182
Last Close Price
0.601.2412.5217.1130.2550.75

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Forward PE
-1.378.717.117.117.88
PB Ratio
0.250.271.221.191.712.23
P/TBV Ratio
---4.925.194.67

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Debt / Equity Ratio
0.100.020.000.010.010.01
Net Debt / Equity Ratio
-0.13-0.03-0.04-0.28-0.40-0.52
Net Debt / EBITDA Ratio
-0.060.070.711.232.94
Net Debt / FCF Ratio
0.280.090.110.901.452.85
Quick Ratio
0.340.100.094.589.2117.60
Current Ratio
0.840.620.405.959.8418.29
Return on Equity (ROE)
-81.09%-52.42%-47.63%-33.40%-28.48%-27.70%
Return on Assets (ROA)
-26.57%-19.45%-23.83%-21.10%-16.24%-15.80%
Return on Capital Employed (ROCE)
-63.30%-44.80%-52.00%-37.50%-30.40%-17.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
-280.00%-177.45%-43.26%-29.93%-19.03%-7.78%
FCF Yield
-210.98%-125.87%-31.17%-26.73%-16.04%-8.19%
Buyback Yield / Dilution
-154.35%-64.49%-11.16%-3.57%-34.52%-177.28%
SEC Filings: 10-K · 10-Q